Eptifibatide Solid Phase Synthesis Impurity Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The existing preparation methods of eptifibatide generate impurities such as [+1Gly]-eptifibatide, [−1Gly]-eptifibatide, and [−1Harg]-eptifibatide, which reduce product yield and purity, making it difficult to achieve high medication safety.

Innovation Solution

A new solid-phase synthesis method is employed, where protected amino acids are sequentially coupled to form the eptifibatide resin, avoiding the generation of these impurities through specific coupling reactions and purification steps, including acidolysis and oxidation, to obtain high-purity eptifibatide.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If Fmoc solid phase synthesis method is used to prepare eptifibatide, then the peptide can be synthesized on amino resin, but impurities such as [+1Gly]-eptifibatide, [-1Gly]-eptifibatide and [-1Harg]-eptifibatide are generated, reducing product purity

Engineering Contradiction:
Improvesolid phase synthesis capabilityVSAvoidproduct purity
Core Design Contradiction:
Ease of manufactureVSManufacturing precision

Solution Approach 1:

The patent applies preliminary action by pre-protecting the N-terminus of Harg with a specific protecting group (Pbf) before coupling to the resin. This preliminary protection prevents unwanted side reactions and impurity formation during the synthesis process, particularly preventing the formation of [-1Harg]-eptifibatide and other degradation products. The protecting group is strategically placed in advance to control the reaction pathway and ensure high product purity.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent employs parameter changes by optimizing the protecting group strategy - specifically using Pbf protection for Harg's N-terminus instead of conventional Fmoc protection throughout. This parameter change in the protection scheme fundamentally alters the reaction behavior, preventing impurity formation while maintaining the benefits of solid phase synthesis. The specific choice of Pbf group changes the chemical parameters of the synthesis process to achieve both ease of manufacture and high purity.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If successive coupling of protected amino acids is performed, then the peptide sequence can be built, but reaction complexity increases and yield decreases due to multiple coupling steps

Engineering Contradiction:
Improvesynthesis speedVSAvoidsynthesis process complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent applies segmentation by dividing the peptide synthesis into two main segments: first, coupling the C-terminal portion (Trp-Pro-Cys-amino resin) to the resin support; second, coupling the N-terminal portion (Mpr-Harg-Gly-Asp) in reverse order. This segmentation allows each segment to be optimized independently and simplifies the overall process by reducing the number of successive coupling steps required while maintaining the ability to build the complete peptide sequence.

Inventive Principle:
Principle #1Segmentation

3Ease of manufacture

If conventional acidolysis is used to release the peptide from resin, then the peptide can be obtained, but impurities are generated and purification difficulty increases

Engineering Contradiction:
Improvepeptide release capabilityVSAvoidimpurity generation
Core Design Contradiction:
Ease of manufactureVSObject-generated harmful factors

Solution Approach 1:

The patent applies parameter changes by modifying the acidolysis conditions - using a specific combination of trifluoracetic acid (TFA) with additives such as ethanedithiol (EDT) or triisopropylsilane (TIPS) in controlled proportions. This parameter change in the acidolysis composition and conditions enables complete peptide release from the resin while minimizing the formation of degradation impurities. The optimized acidolysis parameters ensure high purity of the released peptide without requiring excessive purification steps.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method significantly improves the yield and purity of eptifibatide to more than 99.5%, ensuring high reaction efficiency and product safety by directly avoiding impurities, thus simplifying the reaction process and enhancing practical application.

Implementation Method 1

successively coupling a protected amino acid or fragment corresponding to the following sequence on amino resin through a solid phase coupling synthesis method to obtain the eptifibatide resin

Methodology Applied
Scientific EffectChemical Bonding: Chemical Bonding

Implementation Method 2

acidolysis of the eptifibatide resin to obtain crude linear peptide eptifibatide

Methodology Applied
Scientific EffectAcidolysis: Hydrolysis

Implementation Method 3

oxidation of the crude linear peptide eptifibatide to obtain crude eptifibatide

Methodology Applied
Scientific EffectOxidation: Oxidation

Data Source

PatentUS9394341B2Eptifibatide preparation method
Publication Date: 2016.07.19 CHENGDU SHENGNUO BIOTEC CO LTD
  • US9394341B2 patent drawing
  • US9394341B2 patent drawing

AI summary

An Eptifibatide preparation method with product purity of more than 99.5%, the method comprising: using a solid phase polypeptide synthesis method to prepare eptifibatide resin, conducting acidolysis on the Eptifibatide resin to obtain a crude Eptifibatide linear peptide product, oxidizing to obtain a crude Eptifibatide product, purifying and exchanging salt to obtain an Eptifibatide finished product; the method using the solid phase polypeptide synthesis method to prepare the eptifibatide resin is: using a solid phase coupling synthesis method to sequentially splice a corresponding protective amino acid or a segment in the following sequence onto amino resin, and obtaining the Eptifibatide resin: X—Y-Trp(R1)-Pro-Cys(R2)-amino resin, wherein R1 is Boc or H, R2 is Trt or Acm, X is Mpr(R2)-Harg(R3), R3 is Pbf or H, and Y is Gly-Asp(OtBu).